Leah Joseph explains how GLP-1 mimics a naturally occurring hormone that signals fullness and stabilizes blood sugar
Moreover, we recently demonstrated that activating GLP-1 receptor by exendin-4 treatment enhances the expression of NAMPT, SIRT1, and AMPK in mouse liver
31,35-37 Prospective trials are needed to further explore this potential adverse event and worsened DR, which is the central premise of the ophthalmic FOCUS trial that is expected to release results in 2026
The comment period for this petition is set to expire on Aug
That is why searches for when will Retatrutide be available often produce estimates, not confirmed dates
While its efficacy profile is compelling, it remains an investigational compound requiring further long-term safety and regulatory evaluation before widespread clinical adoption